Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 2Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 4Plasma cell 3Myeloid 3Dermatologic 3Breast 3Gastrointestinal 2

Conditions

Rectal Neoplasms 1Pancreatic Neoplasms 1Depression 1Colorectal Neoplasms 1Colonic Neoplasms 1Anxiety Disorders 1

Interventions

Colonoscopy 67Blood Specimen Collection 64Standard of Care 60Exercise 59Radiosurgery 53Drug Therapy 49Radiofrequency Ablation 47Endoscopic Mucosal Resection 47Radiotherapy 45Surgical Procedures, Operative 44Methods 43Early Intervention, Educational 40Surveys and Questionnaires 39Oxaliplatin 38Laparoscopy 34Educational Status 34Fluorouracil 33Magnetic Resonance Spectroscopy 28Gemcitabine 26Biopsy 26Preoperative Exercise 25Practice Guidelines as Topic 24Control Groups 24lenvatinib 23Patient Navigation 23Electroporation 23Capecitabine 22camrelizumab 20Saline Solution 20Liver Transplantation 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Flow Cytometry × Gastrointestinal × Clear all
NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Roswell Park Cancer Institute

Phase NA Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT00373022 2010-05-27

Moderate Physical Activity in Helping Patients Recover Physically and Emotionally From Stage II Or Stage III Colorectal Cancer

University of Arizona

Phase NA Completed
45 enrolled
Gastrointestinal

Anxiety Disorders, Colonic Neoplasms, Depression, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡